Lactate Dehydrogenase A Is a Novel Positive Regulator of Vascular Smooth Muscle Cell Ferroptosis During Aortic

Xin Feng1,2, Xin Yi3, Bo Huo1

  • 1Division of Cardiovascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

PubMed

Insights

Lactate dehydrogenase A (LDHA) promotes vascular smooth muscle cell ferroptosis in aortic dissection by suppressing protective molecules. Inhibiting LDHA may offer a new therapeutic strategy for aortic dissection.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Cardiovascular Research

Background:

  • Vascular smooth muscle cell (VSMC) ferroptosis is critical in aortic dissection (AD).
  • The role of glycolysis in VSMC ferroptosis and AD is not fully understood.
  • Glycolysis-related molecules are implicated in VSMC ferroptosis and AD pathogenesis.

Purpose of the Study:

  • To investigate the role of glycolysis, specifically lactate dehydrogenase A (LDHA), in VSMC ferroptosis and AD.
  • To elucidate the molecular mechanisms linking LDHA to ferroptosis in AD.
  • To identify LDHA as a potential therapeutic target for AD.

Main Methods:

  • Bioinformatics analysis of glycolysis-related molecules in VSMC ferroptosis and AD.
  • In vitro experiments using VSMCs treated with cystine deprivation or imidazole ketone erastin.
  • Analysis of clinical specimens from patients with AD.
  • Investigation of the interaction between LDHA and nuclear factor (erythroid-derived 2)-like 2 (NRF2).

Main Results:

  • LDHA overexpression promoted VSMC ferroptosis and lipid peroxidation.
  • Elevated LDHA levels in dissected aortae correlated negatively with ferroptosis suppressors GPX4, SLC7A11, and FSP1.
  • LDHA overexpression suppressed GPX4, SLC7A11, and FSP1 expression.
  • NRF2 activation reversed LDHA's pro-ferroptotic effects in VSMCs.
  • LDHA interacts with NRF2, mediating VSMC ferroptosis in AD.

Conclusions:

  • LDHA plays a significant role in VSMC ferroptosis and AD development via the NRF2 pathway.
  • Targeting LDHA could be a promising therapeutic strategy for aortic dissection.